HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael W Sill Selected Research
Michael W Sill Research Topics
Disease
34
Neoplasms (Cancer)
11/2020 - 08/2005
22
Disease Progression
01/2020 - 09/2007
20
Carcinoma (Carcinomatosis)
10/2020 - 08/2005
14
Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 09/2008
14
Endometrial Neoplasms (Endometrial Cancer)
12/2019 - 05/2007
8
Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2020 - 03/2009
5
Hypertension (High Blood Pressure)
02/2018 - 11/2007
5
Pain (Aches)
07/2015 - 11/2007
5
Ovarian Epithelial Carcinoma
03/2012 - 11/2007
4
Neutropenia
01/2017 - 07/2008
4
Carcinosarcoma
11/2012 - 05/2010
3
Fistula
10/2017 - 03/2009
3
Leiomyosarcoma
01/2017 - 09/2007
3
Anemia
07/2015 - 03/2009
3
Fatigue
07/2015 - 07/2009
3
Vomiting
08/2012 - 09/2011
3
Thrombocytopenia (Thrombopenia)
04/2012 - 02/2011
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011 - 03/2009
2
Body Weight (Weight, Body)
10/2020 - 02/2014
2
Diarrhea
01/2019 - 02/2011
2
Abdominal Pain (Pain, Abdominal)
01/2019 - 04/2012
2
Nausea
01/2019 - 04/2012
2
Thromboembolism
10/2017 - 11/2007
2
Dyspnea (Shortness of Breath)
07/2015 - 11/2007
2
Febrile Neutropenia
04/2012 - 02/2011
1
Hypoxia (Hypoxemia)
02/2018
1
Wounds and Injuries (Trauma)
10/2017
1
Hemorrhage
10/2017
1
Uterine Cervical Dysplasia
01/2017
1
Intestinal Fistula
01/2016
1
Necrosis
01/2016
1
Vascular Remodeling
09/2015
1
Edema (Dropsy)
07/2015
1
Neoplasm Metastasis (Metastasis)
12/2012
1
Migraine Disorders (Migraine)
08/2012
Drug/Important Bio-Agent (IBA)
16
Bevacizumab (Avastin)
FDA Link
11/2020 - 11/2007
15
Paclitaxel (Taxol)
FDA Link
Generic
01/2019 - 09/2008
11
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2020 - 11/2007
8
Cisplatin (Platino)
FDA Link
Generic
10/2017 - 10/2009
7
Carboplatin (JM8)
FDA Link
Generic
12/2012 - 09/2008
5
Pharmaceutical Preparations
IBA
11/2020 - 07/2009
5
Biomarkers (Surrogate Marker)
IBA
02/2018 - 05/2007
5
Platinum
IBA
06/2014 - 03/2011
4
Topotecan (Hycamtin)
FDA Link
Generic
10/2017 - 03/2011
4
ErbB Receptors (EGF Receptor)
IBA
06/2013 - 08/2005
4
Docetaxel (Taxotere)
FDA Link
12/2012 - 12/2009
3
Cetuximab (Erbitux)
FDA Link
12/2012 - 05/2011
3
Thalidomide (Thalomid)
FDA Link
11/2012 - 05/2007
2
fosbretabulin (combretastatin A4)
IBA
10/2020 - 01/2016
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
12/2019 - 07/2015
2
Phosphotransferases (Kinase)
IBA
01/2019 - 11/2018
2
pazopanib
FDA Link
02/2018 - 01/2018
2
Proteins (Proteins, Gene)
FDA Link
10/2017 - 05/2011
2
Doxorubicin (Adriamycin)
FDA Link
Generic
07/2015 - 12/2009
2
Tyrosine Kinase Inhibitors
IBA
10/2014 - 11/2012
2
Gefitinib (Iressa)
FDA Link
06/2013 - 08/2005
2
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
06/2013 - 11/2012
2
Lapatinib (GW572016)
FDA Link
11/2012 - 03/2012
2
Imatinib Mesylate (Gleevec)
FDA Link
05/2010 - 07/2008
2
Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
IBA
05/2010 - 07/2008
2
paclitaxel poliglumex (XYOTAX)
IBA
12/2008 - 09/2008
1
Tubulin
IBA
10/2020
1
Angiogenesis Inhibitors
IBA
10/2020
1
Ipilimumab
IBA
01/2020
1
Nivolumab
IBA
01/2020
1
GSK2141795
IBA
12/2019
1
trametinib
IBA
12/2019
1
tyrosine receptor (receptor, tyrosine)
IBA
01/2019
1
cabozantinib
IBA
01/2019
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2019
1
Everolimus
FDA Link
11/2018
1
Interleukin-8 (Interleukin 8)
IBA
02/2018
1
Creatinine
IBA
10/2017
1
MLN 8237
IBA
01/2017
1
Celecoxib (Celebrex)
FDA Link
01/2017
1
Tromethamine (Trometamol)
FDA Link
01/2016
1
cediranib (AZD2171)
IBA
09/2015
1
trebananib
IBA
09/2015
1
Angiopoietin-1
IBA
09/2015
1
AZD 6244
IBA
07/2015
1
Mitogen-Activated Protein Kinases
IBA
07/2015
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
06/2015
1
veliparib
IBA
06/2015
1
nintedanib
IBA
12/2014
1
brivanib
IBA
10/2014
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
10/2014
1
Cholesterol
IBA
06/2014
1
poly(ethylene glycol)-co-poly(ethyleneimine)
IBA
06/2014
1
Interleukin-12 (IL 12)
IBA
06/2014
1
Estrogen Receptors
IBA
06/2013
1
progesterone receptor A
IBA
06/2013
1
aflibercept
IBA
12/2012
1
Growth Factor Receptors
IBA
12/2012
1
iniparib
IBA
09/2012
Therapy/Procedure
13
Drug Therapy (Chemotherapy)
01/2020 - 05/2007
12
Therapeutics
10/2020 - 09/2008
3
Radiotherapy
02/2014 - 04/2012
1
Hysterectomy
09/2015
1
TP protocol
07/2015
1
Combination Drug Therapy (Combination Chemotherapy)
02/2014